R-Tech Ueno Overview

  • Founded
  • 1989
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 80
Employees
  • Latest Deal Type
  • PIPE
  • Latest Deal Amount
  • $10M
Latest Deal Amount

R-Tech Ueno General Information

Description

Developer of pharmaceuticals intended to develop solutions for unmet medical needs. The company is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners, enabling its clients with research and development, manufacturing and marketing of drugs, development support, and contract manufacturing services.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • NBF Hibiya Builing 10th Floor
  • 1-1-7 Uchisaiwaicho Chiyoda-ku
  • Tokyo, 100-0011
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

R-Tech Ueno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. PIPE 22-Oct-2015 $10M 0000 Completed Profitable
3. Merger/Acquisition 13-Oct-2015 00000 00000 Completed Profitable
2. IPO 01-Mar-2008 Completed Profitable
1. Early Stage VC Completed Profitable
To view R-Tech Ueno’s complete valuation and funding history, request access »

R-Tech Ueno Patents

R-Tech Ueno Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170020890-A1 Pharmaceutical composition comprising fatty acid derivative Abandoned 19-Jun-2015 0000000000
JP-2014520758-A Process for producing fatty acid derivatives Withdrawn 01-Jul-2011 0000000000
US-9212158-B2 Method for preparing a fatty acid derivative Expired - Fee Related 01-Jul-2011 0000000000
US-20130005996-A1 Method for preparing a fatty acid derivative Granted 01-Jul-2011 0000000000
JP-WO2012176792-A1 Pharmaceutical composition for use in inflammatory, allergic and autoimmune diseases Granted 21-Jun-2011 A61K39/0005

R-Tech Ueno Executive Team (4)

Name Title Board Seat Contact Info
Yukihiko Mashima MD President
Tadashi Hayashi Managing Director
Ryuji Ueno Ph.D Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »

R-Tech Ueno Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R-Tech Ueno Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nissay Capital Venture Capital Minority 000 0000 000000 0
To view R-Tech Ueno’s complete investors history, request access »